S-3 S-3 EX-FILING FEES 0001367644 Emergent BioSolutions Inc. N/A N/A 0.0001531 0.0001531 0.0001531 0.0001531 0.0001531 0.0001531 0.0001531 0001367644 2025-08-06 2025-08-06 0001367644 1 2025-08-06 2025-08-06 0001367644 2 2025-08-06 2025-08-06 0001367644 3 2025-08-06 2025-08-06 0001367644 4 2025-08-06 2025-08-06 0001367644 5 2025-08-06 2025-08-06 0001367644 6 2025-08-06 2025-08-06 0001367644 7 2025-08-06 2025-08-06 0001367644 8 2025-08-06 2025-08-06 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Emergent BioSolutions Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Equity Common Stock, $0.001 par value per share 457(o)
Equity Preferred Stock, $0.001 par value per share 457(o)
Other Warrants 457(o)
Debt Debt Securities 457(o)
Equity Depositary Shares 457(o)
Other Rights 457(o)
Other Units 457(o)
Fees to be Paid 1 Unallocated (Universal) Shelf 457(o) $ 250,000,000.00 0.0001531 $ 38,275.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 250,000,000.00

$ 38,275.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 38,275.00

Offering Note

1

(1) An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder, which together shall have an aggregate initial offering price not to exceed $250,000,000. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement shall also cover any additional securities of the registrant that may become issuable by reason of any stock split, stock dividends or similar transaction or anti-dilution adjustments. (2) Each unit will represent an interest in one or more other securities registered hereunder, which may or may not be separable from one another.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Rule 457(p)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date

N/A N/A N/A N/A N/A N/A N/A N/A